Acorda Therapeutics Inc RPE
Was ist das RPE von Acorda Therapeutics Inc?
RPE von Acorda Therapeutics Inc ist $343.866k
Was ist die Definition von RPE?
Umsatz pro Mitarbeiter (RPE) ist der Umsatz geteilt durch die Anzahl der Mitarbeiter einer Organisation.
RPE von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acorda Therapeutics Inc
Was macht Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Unternehmen mit rpe ähnlich Acorda Therapeutics Inc
- National Bank of Canada hat RPE von CAD$342.936k
- Revlon hat RPE von $343.083k
- Compagnie Industrielle et Financiere d'Entreprises SA hat RPE von €343.146k
- Plastic Omnium SA hat RPE von €343.218k
- Burelle SA hat RPE von €343.584k
- Valmec hat RPE von AUD$343.628k
- Acorda Therapeutics Inc hat RPE von $343.866k
- Mondi plc hat RPE von €344.038k
- Mondi Plc hat RPE von €344.038k
- Edvantage Ltd hat RPE von ¥344.076k
- Sabre Corp hat RPE von $344.117k
- FinTech Chain hat RPE von ¥344.122k
- People's United hat RPE von $344.149k